All Categories
- Womens Clothing & Accessories
- Mens Clothing & Accessories
- Kid’s & Baby Selection
- Jewelry & Watches
- Sports and Outdoors
- Shoes
- Bags
- Weddings & Special Events
- Cosplay & Costumes
- Pet Products
The Affordable Care Act’s primary objectives are to transform the current U.S. healthcare ecosystem into one that is:
If we were to rate the current progress of ACA, the healthcare sectors would have a lot going for them, but looking ahead, it may be a bumpy ride over the next few years with a lot more work required. As we benchmark the financial outlook for the first quarter of 2018, the positive indicators show healthcare companies’ balance sheets are strong, overall cost structures continue to improve, and stocks have good dividend yields. Continued demand appears to be on the rise for healthcare products and services, partly as a result of the growth of our aging population. Unfortunately, these positive factors are being countered by several negative indicators, including political volatility and uncertainty facing ACA and growing national deficit that could change some of the funding sources currently earmarked for the healthcare sector.
Prior to the implementation of ACA, it was well recognized by both the public and private sector that our healthcare system was not sustainable and we were on the road toward the “perfect storm.” The growing swell was influenced by 18% of GNP directly attributed to healthcare and expected to rise to 30% of GNP by 2050; care demand on the rise with over 25% of the population having multiple chronic disease and growth of chronic disease predicted to grow 1% per year until 2030; and consumer-centric care driving health and wellness to avoid higher out of pocket financial subsidies and chronic conditions. Even more alarming were statistics such as these:
Adding to this trend is the fact that there will be a shortage of over 100,000 physicians by 2030.
Despite these mounting challenges, in today’s healthcare system, providers are expected and incented to perform at a higher level. As a key healthcare supply chain stakeholder and the routine “point of touch” with the consumer, pharmacy also plays a critical role in patient engagement, stepping up and delivering long-term expected outcomes given the headwinds of continued pressures of lower reimbursement, more governmental oversight, and expanded scope of responsibilities relating to access and coverage, emphasizing quality and coordinated accountable care, and expanding emphasis on addressing chronic care conditions.
The key to achieving successful outcomes is developing a comprehensive consumer engagement strategy by optimizing bi-directional communication: When, where, and how you reach consumers matters. The key areas of opportunities include a platform for greater access, medication adherence, predictive analytics that would share insight from patient data for continuous and sustainable insight, and solutions that personalize management and optimize patient care.
By increasing the involvement of patients in their own healthcare, enabling them to manage their wallet spend and proactively avoid health problems and better manage their conditions, we create a changing patient-centered technology ecosystem. Emerging technology helps improve access, efficiency, and quality of care by putting the patient in the center of the digital experience to drive patient empowerment and engagement.
Based on feedback from the pharmacy community, here several key enabling technology initiatives that are being successfully integrated into business models:
Data, Data, Data! Including data analytics, artificial intelligence interoperability, and collaboration
Growth of Telehealth Greater access, medication adherence, quality of care
Smart Devices and Digital Medicine Mobile platforms encourage better patient engagement resulting in better outcome
As digital health technology continues to focus on patient empowerment and engagement, 2018 is likely to be a game-changer year for the healthcare sector, driving improved access and coverage and increased coordination and quality of care, ultimately leading to better management of the spend in our current healthcare system.
David J. Fong, PharmD, is president of Dave Fong Rx Consulting, Inc. A former senior retail pharmacy executive for Fortune 100 and Fortune 500 companies, he is recognized as one of the U.S. and Canada’s business and professional healthcare leaders, leveraging his knowledge and experience working with pharmaceutical manufacturers, distributors, retailers, payers, and healthcare technology companies to bring value to the industry and the consumer.